Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 179

1.

Tumour necrosis factor-alpha infusion produced insulin resistance but no change in the incretin effect in healthy volunteers.

Nielsen ST, Lehrskov-Schmidt L, Krogh-Madsen R, Solomon TP, Lehrskov-Schmidt L, Holst JJ, Møller K.

Diabetes Metab Res Rev. 2013 Nov;29(8):655-63. doi: 10.1002/dmrr.2441.

PMID:
23904405
2.

The effect of 8 days of strict bed rest on the incretin effect in healthy volunteers.

Nielsen ST, Harder-Lauridsen NM, Benatti FB, Wedell-Neergaard AS, Lyngbæk MP, Møller K, Pedersen BK, Krogh-Madsen R.

J Appl Physiol (1985). 2016 Mar 15;120(6):608-14. doi: 10.1152/japplphysiol.00821.2015. Epub 2015 Dec 17.

3.

Reduced glucose tolerance and insulin resistance induced by steroid treatment, relative physical inactivity, and high-calorie diet impairs the incretin effect in healthy subjects.

Hansen KB, Vilsbøll T, Bagger JI, Holst JJ, Knop FK.

J Clin Endocrinol Metab. 2010 Jul;95(7):3309-17. doi: 10.1210/jc.2010-0119. Epub 2010 Apr 21.

PMID:
20410219
4.

Steroid-induced insulin resistance and impaired glucose tolerance are both associated with a progressive decline of incretin effect in first-degree relatives of patients with type 2 diabetes.

Jensen DH, Aaboe K, Henriksen JE, Vølund A, Holst JJ, Madsbad S, Krarup T.

Diabetologia. 2012 May;55(5):1406-16. doi: 10.1007/s00125-012-2459-7.

PMID:
22286551
5.

Altered pattern of the incretin effect as assessed by modelling in individuals with glucose tolerance ranging from normal to diabetic.

Tura A, Muscelli E, Gastaldelli A, Ferrannini E, Mari A.

Diabetologia. 2014 Jun;57(6):1199-203. doi: 10.1007/s00125-014-3219-7.

PMID:
24658843
6.

The incretin effect does not differ in trained and untrained, young, healthy men.

Lund MT, Dalby S, Hartmann B, Helge J, Holst JJ, Dela F.

Acta Physiol (Oxf). 2014 Mar;210(3):565-72. doi: 10.1111/apha.12218. Epub 2014 Jan 16.

PMID:
24354574
7.
8.

Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity.

Knop FK, Aaboe K, Vilsbøll T, Vølund A, Holst JJ, Krarup T, Madsbad S.

Diabetes Obes Metab. 2012 Jun;14(6):500-10. doi: 10.1111/j.1463-1326.2011.01549.x. Epub 2012 Jan 17.

PMID:
22171657
9.

Impaired regulation of the incretin effect in patients with type 2 diabetes.

Bagger JI, Knop FK, Lund A, Vestergaard H, Holst JJ, Vilsbøll T.

J Clin Endocrinol Metab. 2011 Mar;96(3):737-45. doi: 10.1210/jc.2010-2435. Epub 2011 Jan 20.

PMID:
21252240
10.

The incretin effect in critically ill patients: a case-control study.

Nielsen ST, Janum S, Krogh-Madsen R, Solomon TP, Møller K.

Crit Care. 2015 Nov 16;19:402. doi: 10.1186/s13054-015-1118-z.

11.

The effects of TNF-α on GLP-1-stimulated plasma glucose kinetics.

Lehrskov-Schmidt L, Lehrskov-Schmidt L, Nielsen ST, Holst JJ, Møller K, Solomon TP.

J Clin Endocrinol Metab. 2015 Apr;100(4):E616-22. doi: 10.1210/jc.2014-4244. Epub 2015 Feb 12.

PMID:
25675385
12.

Association between circulating cytokine levels, diabetes and insulin resistance in a population-based sample (CoLaus study).

Marques-Vidal P, Bastardot F, von Känel R, Paccaud F, Preisig M, Waeber G, Vollenweider P.

Clin Endocrinol (Oxf). 2013 Feb;78(2):232-41. doi: 10.1111/j.1365-2265.2012.04384.x.

PMID:
22409372
13.
14.

The significance of tumor necrosis factor-alpha in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment.

Chen H, Ren A, Hu S, Mo W, Xin X, Jia W.

Diabetes Res Clin Pract. 2007 Mar;75(3):327-32. Epub 2006 Aug 22.

PMID:
16930761
15.
16.

An oral lipid challenge and acute intake of caffeinated coffee additively decrease glucose tolerance in healthy men.

Beaudoin MS, Robinson LE, Graham TE.

J Nutr. 2011 Apr 1;141(4):574-81. doi: 10.3945/jn.110.132761. Epub 2011 Feb 23.

17.

Recovery of the incretin effect in type 2 diabetic patients after biliopancreatic diversion.

Novaes FS, Vasques AC, Pareja JC, Knop FK, Tura A, Chaim ÉA, Geloneze B.

J Clin Endocrinol Metab. 2015 May;100(5):1984-8. doi: 10.1210/jc.2014-4042. Epub 2015 Mar 5.

PMID:
25742514
18.

Influence of TNF-alpha and IL-6 infusions on insulin sensitivity and expression of IL-18 in humans.

Krogh-Madsen R, Plomgaard P, Møller K, Mittendorfer B, Pedersen BK.

Am J Physiol Endocrinol Metab. 2006 Jul;291(1):E108-14. Epub 2006 Feb 7.

19.

Insulin secretion and incretin hormones after oral glucose in non-obese subjects with impaired glucose tolerance.

Rask E, Olsson T, Söderberg S, Holst Jj Jj, Tura A, Pacini G, Ahrén B.

Metabolism. 2004 May;53(5):624-31.

PMID:
15131768
20.

What is the contribution of differences in three measures of tumor necrosis factor-alpha activity to insulin resistance in healthy volunteers?

Zavaroni I, Numeroso F, Dongiovanni P, Ardigò D, Valenti L, Fracanzani Al, Valtuena S, Delsignore R, Fargion S, Reaven GM.

Metabolism. 2003 Dec;52(12):1593-6.

PMID:
14669161

Supplemental Content

Support Center